CAMP4 Therapeutics Corporation (CAMP) vs Lineage Cell Therapeutics, Inc. (LCTX)
CAMP4 Therapeutics Corporation and Lineage Cell Therapeutics, Inc. are both Biotechnology companies. CAMP4 Therapeutics Corporation and Lineage Cell Therapeutics, Inc. are of similar size ($241.0M and $239.7M). Lineage Cell Therapeutics, Inc. has the higher net margin (−246.6% vs −2,543.7%) and the lower return on invested capital (−186.8% vs 0.00%). Across the 15 metrics below, Lineage Cell Therapeutics, Inc. leads on 10 and CAMP4 Therapeutics Corporation on 5.
Valuation
Profitability
| Metric | CAMP | LCTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 99.46% | 65.16% |
| Operating margin | (1,254.22%) | (205.23%) | 0.00% |
| Net margin | (2,543.74%) | (246.58%) | 0.00% |
| Free cash flow margin | (680.36%) | (186.43%) | 0.00% |
| Return on equity | (545.85%) | (60.35%) | (57.72%) |
| Return on assets | (148.23%) | (32.75%) | (49.22%) |
| Return on invested capital | 0.00% | (186.79%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack